KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Twist Bioscience (TWST) Depreciation and Depletion (2022 - 2025)

Twist Bioscience (TWST) has disclosed Depreciation and Depletion for 2 consecutive years, with $7.6 million as the latest value for Q3 2023.

  • On a quarterly basis, Depreciation and Depletion changed N/A to $7.6 million in Q3 2023 year-over-year; TTM through Sep 2023 was $24.1 million, a N/A change, with the full-year FY2025 number at $23.8 million, down 12.82% from a year prior.
  • Depreciation and Depletion was $7.6 million for Q3 2023 at Twist Bioscience, up from $6.9 million in the prior quarter.
  • In the past five years, Depreciation and Depletion ranged from a high of $7.6 million in Q3 2023 to a low of $3.9 million in Q4 2022.